A detailed history of Allspring Global Investments Holdings, LLC transactions in Siga Technologies Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 211,236 shares of SIGA stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
211,236
Previous 77,639 172.07%
Holding current value
$1.25 Million
Previous $589,000 141.6%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$6.74 - $11.97 $900,443 - $1.6 Million
133,597 Added 172.07%
211,236 $1.42 Million
Q2 2024

Jul 26, 2024

BUY
$6.32 - $10.46 $158,714 - $262,681
25,113 Added 47.81%
77,639 $589,000
Q1 2024

Apr 18, 2024

BUY
$4.51 - $8.92 $24,660 - $48,774
5,468 Added 11.62%
52,526 $449,000
Q4 2023

Jan 25, 2024

BUY
$4.82 - $6.25 $5,634 - $7,306
1,169 Added 2.55%
47,058 $263,000
Q3 2023

Oct 27, 2023

BUY
$4.32 - $5.77 $198,240 - $264,779
45,889 New
45,889 $240,000
Q2 2023

Jul 18, 2023

BUY
$5.0 - $6.31 $220,145 - $277,822
44,029 Added 151.11%
73,167 $369,000
Q1 2023

Apr 13, 2023

BUY
$5.23 - $8.42 $22,530 - $36,273
4,308 Added 17.35%
29,138 $167,000
Q4 2022

Jan 23, 2023

SELL
$7.29 - $10.14 $3,958 - $5,506
-543 Reduced 2.14%
24,830 $183 Million
Q3 2022

Oct 26, 2022

SELL
$10.02 - $26.15 $1.16 Million - $3.03 Million
-116,039 Reduced 82.06%
25,373 $261,000
Q2 2022

Jul 25, 2022

SELL
$6.5 - $13.68 $849,738 - $1.79 Million
-130,729 Reduced 48.04%
141,412 $1.64 Million
Q1 2022

May 02, 2022

SELL
$5.96 - $7.61 $1.17 Million - $1.49 Million
-195,629 Reduced 41.82%
272,141 $1.93 Million
Q4 2021

Jan 28, 2022

BUY
$6.96 - $9.26 $3.26 Million - $4.33 Million
467,770 New
467,770 $3.52 Million

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $434M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.